A Prospective, Single-Center, Randomized, Triple-Blinded, Placebo-Controlled Study of IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2018
At a glance
- Drugs Anakinra (Primary)
- Indications Ligament injuries; Osteoarthritis
- Focus Therapeutic Use
- 06 Apr 2018 Last checked against ClinicalTrials.gov record.
- 02 Apr 2018 Planned initiation date changed from 1 Mar 2018 to 1 Jun 2018.
- 08 Feb 2018 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.